VBL Therapeutics Competitors and Similar CompaniesClear all
VBL Therapeutics's competitors and similar companies include Takeda and Shanghai Junshi Biosciences.
 VBL Therapeutics VBL Therapeutics (also known as Notable Labs, נוטבל לאבס, בע"מ; formerly Vascular Biogenics) is a biopharmaceutical company focused on the development of treatments for cancer. |  Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. |  Shanghai Junshi Biosciences Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases. | |
Founding Date | Founding Date 2000 | Founding Date 1781 | Founding Date 2012 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Modi'in-Maccabim-Re'ut, IL HQ | Locations Shanghai, CN HQ | |
Employees | Employees 7600% increase | Employees 47,4554% decrease | Employees 2,578 |
Valuation ($) | Valuation ($) 12.1 m | Valuation ($) 43.7 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $310k (FY, 2023) | Revenue (est.) ¥4.5t (FY, 2026) | Revenue (est.) ¥2.4b (FY, 2025) |
Cost of goods | Cost of goods $197k (FY, 2023) | Cost of goods ¥850.5b (FY, 2026) | Cost of goods ¥466.5m (FY, 2025) |
Gross profit | Gross profit $113k (FY, 2023) | Gross profit ¥3.7t (FY, 2026) | Gross profit ¥2b (FY, 2025) |
Net income | Net income ($11.3m) (FY, 2023) | Net income ¥192b (FY, 2026) | Net income (¥1b) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Takeda
HQ
Tokyo, JP
Employees
47,455↓ 4% decrease
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View companyShanghai Junshi Biosciences
HQ
Shanghai, CN
Employees
2,578
Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.
View company